Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : PYNG Technologies -- Ignore unavailable to you. Want to Upgrade?

To: m. jacobs who wrote (4059)	6/26/1999 11:51:00 PM
From: Jack Rayfield	Read Replies (1) \| Respond to of 8117

Dear Mr. Jacobs Thanks for the update on Discovery Expo 99. It sounds like you were busy (a package given out every 6 minutes on average is impressive). The Emerging Company Report exposure sounds great. I know that this conference will bear fruit. Will the taped interview with ECR be available eventually on the website or on ViaVid? I have not heard of ECR and I do not think that any of the cable channels in NC carry their program or I am sure I would have noticed it. But if their market is the New York metropolitan area then it has got to be great exposure. I appreciate you sharing comments on the event. I know that I was extremely interested in how it went. You make a good point about the cash that would be raised if all options and warrants are exercised. As you state this should be more than enough to cover any forseeable need for cash. My point is that I consider these shares outstanding in any analysis I do because I am an optimist. Looking on the positive side I think that before they expire Pyng's stock will be much higher than their exercise price so future EPS must be assumed to be diluted by them. Could you give us some comments on the SAEM conference in Boston last month? Since there was no news release, I am curious how it went. Obviously it was great exposure of a different nature. It seems that this was the perfect audience to hear the FAST 1 success story. The fact that the poster presentation included such a wide variety of emergency medical professionals that confirmed the performance of the device had to be impressive. I would appreciate any comments you can share that will give some insight in to the conference participant's reaction to the presentation and any new contacts made. It is good news that FAST 1 is being used as a first line access device in the case of cardiac arrest in some areas. I think that this type of expanded protocol for use if adopted by a significant number of locations multiplies the potential market geometrically. I look forward to Dr. Johnson's comments on this subject. And thanks again for your posts on this forum. Obviously every development can not be reported in a news release. But I think that this forum provides Pyng with a great medium to keep shareholder up todate on these developments. Also thanks to Dr. Johnson for his timely post stating that the design concept was finalized before the Expo, which is very good news and I am sure this demonstrated progress was invaluable in your discussions with the Expo attendees. Thanks Jack

To: m. jacobs who wrote (4059)	6/27/1999 12:03:00 AM
From: LOR	Read Replies (1) \| Respond to of 8117

Geezz Mike, My cousin at LaGuardia tells me that all he found in your bag was a fine selection of men's clothes, some cheap after shave and some kind of report reviewing the BIG and FAST-1. No sales orders and not even any fund manager or "analyst" business cards. Ah well, expect your bag to get to you by next Thursday. LOR P.S.- Would you or Doc Johnson be kind enough to tell us whether or not the "Production Design" has been finalized or merely the final "design concept"?

To: m. jacobs who wrote (4059)	7/9/1999 9:39:00 AM
From: LOR	Read Replies (2) \| Respond to of 8117

Request For the Following Commitment From Mr. M. Jacobs Dear Mr. Jacobs: I know that you and your staff have been working hard, yet the sales of the FAST1 are much slower than investors' anticipated based upon previous statements. I hope this does not come as a surprise but I really do want to see PYNG become a success with a very profitable bottom line. One of the problems I think which must be overcome is the gradual loss of faith by investors in PYNG's PR's and / or comments made by PYNG staff over the past several years. If I am not mistaken, the following statements have been made: 5/7/97 "In anticipation of commercial sales beginning in the last quarter of 1997 Pyng Medical Corp. will now start booking firm pre-market orders for the F.A.S.T. 1TM System. " 10/2/97 "That's why it plans to hit the U.S. market within six months with its FAST 1 intraosseous infusion system that delivers fluids through bone marrow into adults", Pyng vice president of research and development David L. Johnson, Ph.D., said Tuesday at MEDICAL DATA INTERNATIONAL INC.'S (Irvine, CA) "Emerging Medical Technologies East" conference." 12/23/97 "The results of these studies will provide the late adopters with the evidence they need to commit themselves to purchase. By that time, Pyng's large-scale production will be in place to meet the resulting demand." It is clear from many of your past PYNG sales projections going back to the mid 1990's that PYNG felt at the time that significant sales of PYNG produced IO devices would be achieved long before now. I suspect that as CEO the process of bringing IO devices to market has been a somewhat trying experience and that you fully realize that PYNG's forecasts were not achieved because you did not accurately gauge the time required to overcome the many obstacles in PYNG's path. I tend to think of you as a man with a vision. I am sure you have the "end result" of all the hard work very clearly set in your mind. I am also confident that with the right management PYNG will "arrive" so to speak at significant volume production sales of the FAST-1. However, a man with a vision may not be what PYNG requires as CEO at this time. I, and I know many other PYNG investors, believe PYNG needs a sales oriented CEO who can find innovative ways of overcoming the final hurdles to significant volume sales. If, after not achieving your previous forecasts for so many years you still feel you are the right man for the job then I propose that you publicly set a target of selling 30,000 FAST1 units during the period October 1, 1999 to September 30, 2000. In order to further boost investor confidence a public statement on your part to the effect that you will tender your resignation in the event that you do not reach that target would be appreciated by many. It is a smart man who knows his own limits and who knows when to pass on certain responsibilities for which he may not be ideally suited over to someone with the particular skills needed. Naturally, as Chairman of the Board with significant share holdings your overall control of PYNG would not be affected. Provided you gave the new CEO adequate leeway to exercise his / her skills, it seems obvious that the chances of success for all shareholders would be significantly increased. By stepping up to the plate and making a firm commitment to Pyng investors I believe you will restore a higher degree of confidence which will not go unnoticed by the investment community. It will also show that you are not blind to your own limitations and will set you and PYNG head and shoulders above so many other companies that ended up out of business even though they had promising products but not the right people to bring those products to market. So Mr. Jacob's, are you now prepared to make the commitment to PYNG shareholders to sell 30,000 FAST-1 units in the next fiscal year or resign in the event that PYNG can not achieve this seemingly modest objective? A straight forward response posted to this tread would be appreciated so that all interested parties can see your commitment. sincerely, LOR